Drug Information
General Information | ||||||
---|---|---|---|---|---|---|
Drug ID |
DR00551
|
|||||
Drug Name |
Cefamandole
|
|||||
Synonyms |
(6R,7R)-7-(R)-Mandelamido-3-(((1-methyl-1H-tetrazol-5-yl)thio)methyl)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-carboxylic acid; (6R,7R)-7-[[(2R)-2-hydroxy-2-phenylacetyl]amino]-3-[(1-methyltetrazol-5-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; (6R,7R)-7-{[(2R)-2-hydroxy-2-phenylacetyl]amino}-3-{[(1-methyl-1H-tetrazol-5-yl)sulfanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; (6R,7R)-7-{[(2R)-2-hydroxy-2-phenylacetyl]amino}-3-{[(1-methyl-1H-tetrazol-5-yl)thio]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; 7beta-[(2R)-2-hydroxy-2-phenylacetamido]-3-{[(1-methyl-1H-tetrazol-5-yl)sulfanyl]methyl}ceph-3-em-4-carboxylic acid; Cefadole; Cefamandole (USAN/INN); Cefamandolum
|
|||||
Drug Type |
Small molecular drug
|
|||||
Indication | Infections by susceptible microorganisms [ICD11: 1H0Z] | Approved | [1] | |||
Therapeutic Class |
Antibiotics
|
|||||
Structure |
|
|||||
3D MOL | 2D MOL | |||||
Formula |
C18H18N6O5S2
|
|||||
Canonical SMILES |
CN1C(=NN=N1)SCC2=C(N3C(C(C3=O)NC(=O)C(C4=CC=CC=C4)O)SC2)C(=O)O
|
|||||
InChI |
InChI=1S/C18H18N6O5S2/c1-23-18(20-21-22-23)31-8-10-7-30-16-11(15(27)24(16)12(10)17(28)29)19-14(26)13(25)9-5-3-2-4-6-9/h2-6,11,13,16,25H,7-8H2,1H3,(H,19,26)(H,28,29)/t11-,13-,16-/m1/s1
|
|||||
InChIKey |
OLVCFLKTBJRLHI-AXAPSJFSSA-N
|
|||||
CAS Number |
CAS 34444-01-4
|
|||||
Pharmaceutical Properties | Molecular Weight | 462.5 | Topological Polar Surface Area | 201 | ||
Heavy Atom Count | 31 | Rotatable Bond Count | 7 | |||
Hydrogen Bond Donor Count | 3 | Hydrogen Bond Acceptor Count | 10 | |||
XLogP |
-0.9
|
|||||
PubChem CID | ||||||
PubChem SID |
10302112
, 103023094
, 103331360
, 104133790
, 109719094
, 11466775
, 11467895
, 11486409
, 124766405
, 126621136
, 126657633
, 134223450
, 134337744
, 134999140
, 135883952
, 136357154
, 137003418
, 142043553
, 14833916
, 15331577
, 160964623
, 175268221
, 175442895
, 179150349
, 184546701
, 223668260
, 226423119
, 250133947
, 252347133
, 46508882
, 47349540
, 47795225
, 48019109
, 48318624
, 48415710
, 57405452
, 602882
, 77400779
, 7849403
, 7978872
, 81044354
, 85788971
, 87322628
, 9096
, 92719034
, 93575875
|
|||||
ChEBI ID |
CHEBI:3480
|
|||||
TTD Drug ID | ||||||
DT(s) Transporting This Drug | PEPT1 | Transporter Info | Peptide transporter 1 | Substrate | [2] | |
References | ||||||
1 | Cefamandole was approved by FDA. The official website of the U.S. Food and Drug Administration. (2019) | |||||
2 | Intestinal transport of beta-lactam antibiotics: analysis of the affinity at the H+/peptide symporter (PEPT1), the uptake into Caco-2 cell monolayers and the transepithelial flux. Pharm Res. 1999 Jan;16(1):55-61. |
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.